BIVDA Press Releases

19Apr

BIVDA Welcomes NICE Five Year Plan

BIVDA welcomes NICE Five Year Plan

 

BIVDA, the trade association for British IVD companies,  has welcomed the publication of NICE’s five year strategy document. The document runs from 2021 to 2026 and is designed to ensure the organisation remains “excellent”, more dynamic and more collaborative in their work. According to NICE,  the plan puts science and evidence at the heart of health and care decision making, while keeping ahead of the challenges of a rapidly changing world.  External stakeholders including key opinion leaders, patient groups and partner organisations in healthcare and care were consulted as part of the document’s elaboration.

 

COVID-19 has highlighted the need for accelerating access to new and effective treatments, practices and technologies. Real-world data must be integrated into evaluation processes in order to improve decision-making.  Further focus on diagnostic innovation is mentioned, as NICE seeks to extend technological innovation past only traditional drugs and medical devices. NICE guidance is to be embedded in partners’ regulation monitoring and improvement frameworks.

 

Commenting on the document, BIVDA Chief Executive Doris-Ann Williams said;

 

“NICE plays a vital role in ensuring high standards and safety and we welcome the plans to extend technological innovation to diagnostics over and above the traditional focus on drugs and medical devices. A dynamic, thriving diagnostic sector is vital to the recovery of the NHS post-pandemic. We look forward to working with NICE on the rollout of the strategy.”

 

ENDs

 

Related

BIVDA response to Government’s announcement of new improvements to the Accelerated Access Collaborative

BIVDA responds to Government’s announcement of new improvements to the Accelerated Access Collabora...

Read More >

BIVDA statement on the publication of the NHS Long Term Plan

Doris-Ann Williams, Chief Executive of BIVDA, comments on the publication of the NHS Long Term Plan ...

Read More >

European Parliament endorses new Regulation on In Vitro Diagnostics

The European Parliament has endorsed the new Regulation on In Vitro Diagnostics (IVDR), a developmen...

Read More >

Member Press Release - BIVDA Member Randox Processes 10 Millionth COVID-19 Test

RANDOX PROCESSES ITS 10 MILLIONTH COVID-19 TEST AND DETAILS INVESTMENT IN TESTING CAPACITY Rand...

Read More >

BIVDA Welcomes AAR Funding Announcement

Commenting on the Government’s announcement today (14 July 2017) regarding funding for the Accelera...

Read More >

New report highlights the value of near patient testing

BIVDA launches new report on the value of near patient testing

Read More >